Flagship Harbor Advisors, LLC Astrazeneca PLC Transaction History

Flagship Harbor Advisors, LLC

$1.82 Billion
Q4 2024

A detailed history of Flagship Harbor Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 7,822 shares of AZN stock, worth $589,778. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,822

Previous 8,022 2.49%

Holding current value

$589,778

Previous $625,000 18.08%

% of portfolio

0.03%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$63.2 - $79.58 $12,640 - $15,916	-200 Reduced 2.49%	7,822 $512,000
Q3 2024 Oct 21, 2024	BUY	$76.67 - $87.62 $8,357 - $9,550	109 Added 1.38%	8,022 $625,000
Q1 2024 Apr 16, 2024	BUY	$61.03 - $69.57 $11,351 - $12,940	186 Added 2.41%	7,913 $536,000
Q4 2023 Jan 10, 2024	BUY	$61.89 - $69.28 $3,403 - $3,810	55 Added 0.72%	7,727 $520,000
Q3 2023 Oct 17, 2023	BUY	$64.85 - $71.7 $713 - $788	11 Added 0.14%	7,672 $519,000
Q2 2023 Jul 11, 2023	SELL	$69.91 - $75.81 $3,495 - $3,790	-50 Reduced 0.65%	7,661 $548,000
Q1 2023 Apr 12, 2023	SELL	$63.15 - $71.6 $17,682 - $20,048	-280 Reduced 3.5%	7,711 $535,000
Q4 2022 Jan 13, 2023	SELL	$54.21 - $70.44 $6,776 - $8,805	-125 Reduced 1.54%	7,991 $0
Q3 2022 Oct 13, 2022	SELL	$53.02 - $135.75 $1,484 - $3,801	-28 Reduced 0.34%	8,116 $445,000
Q2 2022 Jul 13, 2022	SELL	$59.26 - $71.14 $47,585 - $57,125	-803 Reduced 8.98%	8,144 $538,000
Q1 2022 Apr 13, 2022	SELL	$55.72 - $67.12 $1,671 - $2,013	-30 Reduced 0.33%	8,947 $594,000
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $45,214 - $53,425	837 Added 10.28%	8,977 $523,000
Q2 2021 Jul 26, 2021	SELL	$48.42 - $60.18 $52,487 - $65,235	-1,084 Reduced 11.75%	8,140 $488,000
Q1 2021 May 03, 2021	SELL	$47.16 - $54.44 $46,499 - $53,677	-986 Reduced 9.66%	9,224 $459,000
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $76,952 - $92,019	-1,586 Reduced 13.45%	10,210 $510,000
Q3 2020 Oct 13, 2020	BUY	$53.07 - $61.1 $117,178 - $134,908	2,208 Added 23.03%	11,796 $646,000
Q2 2020 Jul 31, 2020	BUY	$43.1 - $55.31 $37,583 - $48,230	872 Added 10.0%	9,588 $507,000
Q1 2020 May 12, 2020	BUY	$37.79 - $51.33 $52,717 - $71,605	1,395 Added 19.05%	8,716 $389,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $3,099 - $3,683	73 Added 1.01%	7,321 $365,000
Q3 2019 Oct 22, 2019	BUY	$40.12 - $45.47 $12,236 - $13,868	305 Added 4.39%	7,248 $323,000
Q2 2019 Jul 22, 2019	BUY	$37.28 - $41.68 $7,456 - $8,336	200 Added 2.97%	6,943 $286,000
Q1 2019 Apr 15, 2019	SELL	$35.49 - $43.02 $3,513 - $4,258	-99 Reduced 1.45%	6,743 $272,000
Q4 2018 Jan 28, 2019	SELL	$36.86 - $41.49 $217,363 - $244,666	-5,897 Reduced 46.29%	6,842 $259,000
Q3 2018 Nov 05, 2018	SELL	$34.76 - $39.72 $66,183 - $75,626	-1,904 Reduced 13.0%	12,739 $503,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $290,841 - $311,886	8,418 Added 135.23%	14,643 $514,000
Q1 2018 Apr 24, 2018	SELL	$32.97 - $36.63 $5,077 - $5,641	-154 Reduced 2.41%	6,225 $216,000
Q4 2017 Jan 24, 2018	BUY	$32.09 - $34.78 $204,702 - $221,861	6,379	6,379 $227,000

Others Institutions Holding AZN

# of Institutions

1,358

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Account

Flagship Harbor Advisors, LLC Astrazeneca PLC Transaction History